Contact Me - QA VALIDATION ENGINEER CONSULTANT (UK)

+44 79 19 49 39 39 wilsonblaney@gmail.com

Home
LinkedIn Profile
- CV
- Clients
Contact Me
cGMP Reference Guides
Validation Protocols
Validation Books
Blog
- Privacy Policy
- Copyright

Select Page

MHRA Drug Safety Alerts

Rivaroxaban (Xarelto▼) after transcatheter aortic valve replacement: increase in all-cause mortality, thromboembolic and bleeding events in a clinical trial October 11, 2018
Ritonavir-containing products: reports of interaction with levothyroxine leading to reduced thyroxine levels October 11, 2018

MHRA Recall Notices

Class 2 Medicines Recall: Ozurdex 700 micrograms intravitreal implant in applicator manufactured by Allergan Pharmaceuticals Ireland (MDR 95-08/18) October 5, 2018
Class 4 defect information: Caspofungin 70mg powder for concentrate for solution for infusion (MDR 11-09/18) September 18, 2018

FDA Recall Notices

Recall of Bittersweet & Feve Chocolate Bars Due to High Levels of Milk Allergens November 10, 2018
In Association With Sunshine Mills, Lidl Voluntarily Recalls Orlando Brand Grain Free Chicken & Chickpea Superfood Recipe Dog Food Due to Elevated Levels of Vitamin D. November 9, 2018

Categories

EudraLex
FDA Latest News
MHRA News
Novartis
Pharmaceutical Validation Blog
Process Validation Engineer

Recent Posts

Doctors pounce on ‘alarmist,’ ‘horrifying’ Novartis heart-failure ad February 23, 2016
Latest Novartis News February 18, 2016

Home
LinkedIn Profile
Contact Me
cGMP Reference Guides
Validation Protocols
Validation Books
Blog

Designed by Elegant Themes | Powered by WordPress